The most recent systematic review, published last year in an orthopaedic journal, screened 544 papers and found one human study that qualified: a retrospective look at 12 people who had the peptide injected into an arthritic knee, seven of whom reported relief lasting more than six months
They occupy entirely different evidence tiers: Cerebrolysin has decades of clinical trial data and systematic reviews, while Dihexa has only preclinical animal studies with questioned integrity
16 , e1008892 (2020)
Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats
However, its also possible that your dose needs to be adjusted, or that you would benefit from some help in sticking with your medication plan
[3] Protein kinases may possibly impact transcription factors involved in gene expression that enter the nucleus, and potentially modulate the transcription of genes associated with growth hormone synthesis and secretion